Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Avidity Biosciences, Inc. (RNA)  
$24.67 0.62 (2.58%) as of 4:30 Wed 3/27


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 79,511,000
Market Cap: 1.96(B)
Last Volume: 0 Avg Vol: 0
52 Week Range: $4.87 - $24.83
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:

   

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Avidity Biosciences is a biopharmaceutical company developing a new class of RNA therapies called Antibody Oligonucleotide Conjugates (AOCs) designed to combine the specificity of monoclonal antibodies, or mAbs, with the precision of RNA therapeutics to target the root cause of diseases previously untreatable with such therapeutics. Co.'s lead product candidate, AOC 1001, is designed to treat myotonic dystrophy type 1, a rare monogenic muscle disease. Co. pipeline also includes AOC 1044, the lead of three programs for the treatment of Duchenne Muscular Dystrophy, and AOC 1020, designed to treat facioscapulohumeral muscular dystrophy.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 283,402 283,402 283,402 523,502
Total Sell Value $5,980,852 $5,980,852 $5,980,852 $11,449,469
Total People Sold 5 5 5 5
Total Sell Transactions 11 11 11 24
End Date 2023-12-28 2023-09-26 2023-03-28 2022-03-28

   
Records found: 78
  Page 1 of 4  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Levin Arthur A Director   –       •      –    2024-03-19 4 S $23.97 $119,848 D/D (5,000) 14,830 -4%     
   Levin Arthur A Director   –       •      –    2024-03-19 4 OE $1.24 $6,200 D/D 5,000 19,830     -
   Maclean Michael F Chief Financial Officer   •       –      –    2024-03-13 4 S $24.52 $980,760 D/D (40,000) 44,093 1%     
   Maclean Michael F Chief Financial Officer   •       –      –    2024-03-13 4 OE $8.82 $352,800 D/D 40,000 84,093     -
   Levin Arthur A Director   –       •      –    2024-03-12 4 S $22.00 $609,017 D/D (27,641) 14,830 -9%     
   Levin Arthur A Director   –       •      –    2024-03-12 4 OE $1.24 $31,000 D/D 25,000 42,471     -
   Boyce Sarah President and CEO   •       •      –    2024-03-12 4 S $22.63 $633,682 D/D (28,000) 112,117 -9%     
   Boyce Sarah President and CEO   •       •      –    2024-03-12 4 OE $1.24 $34,720 D/D 28,000 140,117     -
   Boyce Sarah President and CEO   •       •      –    2024-03-08 4 S $21.39 $1,796,710 D/D (84,000) 112,117 -15%     
   Boyce Sarah President and CEO   •       •      –    2024-03-08 4 OE $1.24 $104,160 D/D 84,000 196,117     -
   Boyce Sarah President and CEO   •       •      –    2024-03-01 4 S $20.13 $1,691,306 D/D (84,000) 112,117 -23%     
   Boyce Sarah President and CEO   •       •      –    2024-03-01 4 OE $1.24 $104,160 D/D 84,000 196,117     -
   Levin Arthur A Director   –       •      –    2024-01-22 4 AS $10.13 $18,832 D/D (1,859) 17,471 129%     
   Mccarthy Teresa Chief Human Resources Officer   •       –      –    2024-01-22 4 AS $10.13 $20,918 D/D (2,065) 17,035 129%     
   Flanagan W. Michael CSTO   •       –      –    2024-01-22 4 AS $10.13 $41,827 D/D (4,129) 35,871 129%     
   Boyce Sarah President and CEO   •       •      –    2024-01-22 4 AS $10.13 $51,582 D/D (5,092) 44,008 129%     
   Maclean Michael F Chief Financial Officer   •       –      –    2024-01-22 4 AS $10.13 $16,370 D/D (1,616) 16,884 129%     
   Mccarthy Teresa Chief Human Resources Officer   •       –      –    2024-01-20 4 A $0.00 $0 D/D 16,500 17,458     -
   Flanagan W. Michael CSTO   •       –      –    2024-01-20 4 A $0.00 $0 D/D 20,000 20,290     -
   Boyce Sarah President and CEO   •       •      –    2024-01-20 4 A $0.00 $0 D/D 62,500 67,209     -
   Maclean Michael F Chief Financial Officer   •       –      –    2024-01-20 4 A $0.00 $0 D/D 22,500 27,209     -
   Wilson Troy Edward Director   –       •      –    2023-12-12 4 A $0.00 $0 I/I 550,000 300,000     -
   Wilson Troy Edward Director   –       •      –    2023-12-12 4 D $0.00 $0 I/I (550,000) 13,711     -
   Levin Arthur A Director   –       •      –    2023-03-15 4 AS $22.01 $2,201 D/D (100) 19,330 -57%     
   Levin Arthur A Director   –       •      –    2023-03-15 4 OE $1.24 $124 D/D 100 19,430     -

  78 Records found
  1  2  3  4   
  Page 1 of 4
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed